IL6 and rheumatoid arthritis: In RA patients, the increased activation of inflammatory cells causing excessive cytokine production including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 acts on erythropoietin progenitor cells, promoting hemolysis and causing subsequent reduction in the number of circulating red blood cells [35].